Objective: In 2013, Mozambique adopted Option B+, universal lifelong antiretroviral therapy (ART) for all pregnant and lactating women, as national strategy for prevention of mother-to-child transmission of HIV. We analyzed retention in care of pregnant and lactating women starting Option B+ in rural northern Mozambique.
INTRODUCTION
Mozambique has one of the highest HIV prevalences in the world, reaching 10.8% among adults aged 15 to 49 years. Of the 190,000 infected children (1), more than 90% acquired HIV through vertical transmission. The risk of mother-to-child transmission (MTCT) of HIV can be reduced to <5% through a combination of preventive measures, including antiretroviral therapy (ART) for the expectant mother and her newborn child and hygienic delivery conditions (2, 3) .
In 2013, WHO recommended Option B+ as the preferred strategy for the prevention of motherto-child transmission (PMTCT) of HIV. Option B+ consists of lifelong ART for all HIV-infected pregnant and lactating women (PLW), irrespective of their clinical status or CD4 cell count. This strategy is expected to improve the clinical prognosis of HIV-infected women, to reduce the incidence of AIDSrelated conditions and to significantly reduce MTCT (4, 5) . Most importantly, Option B+ simplifies PMTCT strategies and avoids the reliance on CD4 count measurements, which is an important barrier to the timely initiation of ART in many rural African settings (6, 7) . Several studies have also shown its cost-effectiveness (8) (9) (10) (11) (12) . Despite initial optimistic data on retention in Malawi (13) , other reports showed that high losses to follow-up (LTFU) and poor adherence to ART could be major drawbacks of this strategy (14, 15) . In a recent analysis of SolidarMed ART programs in Southern Africa, includ-
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ing health centers in rural Mozambique, LTFU in general HIV care, especially after the first visit, was extremely high (16) . Early LTFU is of particular importance as it also seems to be a bottleneck for retention in Option B+ (15) .
Option B+ was adopted as the National PMTCT strategy by the Mozambican National HIV program in 2013. However, only few studies have assessed the challenges of implementing such a strategy in rural sub-Saharan African settings with poor and undersupplied health care systems (17) . We evaluated retention in care of PLW starting ART under Option B+ in rural Mozambique and compared their outcomes with those of women of childbearing age starting ART for their own health.
We analyzed retention in care from the start of the implementation of Option B+ in decentralized clinical settings in Mozambique, allowing early feedback to national health authorities. We also included a comparison with a historical cohort of pregnant women who started lifelong ART under Option A for their own health at Chronic Diseases Units/HIV clinics.
PATIENTS AND METHODS

Setting
Ancuabe District is situated in the Northern Mozambican Province of Cabo Delgado, where HIV infection accounts for at least 20% of the deaths in the province (18) . In Ancuabe district, about 125,000 people live in 64 villages and in Ancuabe town (19) , of whom 5,600 persons are estimated to be infected with HIV (20) . Ancuabe has no hospital but two big type 1 health centers (HC) and 4 peripher- 
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This article is protected by copyright. All rights reserved. Before Option B+ implementation, pregnant women starting ART for their own health were also attended at Chronic Diseases Units/HIV clinics. Despite the different staffing, antenatal clinics and Chronic Diseases Units/HIV clinics were comparable as they were located in the same facility and provided daily service with similar availability of laboratory and treatment services. All HC offered point-of-care HIV testing at different testing points following national guidelines. CD4 testing was centralized at Ancuabe HC since mid 2012 where a PIMA® machine was located; CD4 samples from other HC were collected and transported to Ancuabe HC weekly. Adherence counselling was done by the ART prescriber and by HIV activists located at every antenatal and HIV clinic in the two type 1 HC and by a single HIV activist shared by the two clinics at the type 2 HC. The national HIV program recommends follow-up visits at 1 week after ART initiation and monthly thereafter for pregnant women and at 2 weeks, 1, 2 and 6 months and every 6 months thereafter for nonpregnant women (21) . Active tracing was started two weeks after a patient did not show up for a scheduled pick up of HIV drugs, according to National recommendations. It consisted of a home visit by an HIV activist. The same tracing procedure was followed for women seeking HIV care for their own health and for Option B+ women.
Study population and data collection
We included all ART-naïve, HIV-infected women of childbearing age (15- 
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Mozambican National Bioethics Committee and all patients provided written informed consent before the data were entered into the database. The study was also approved by the Operational Research Committee of SolidarMed.
To ensure quality of data, one of the investigators (JLG) checked the antenatal care clinic registries to ensure the pregnant/breastfeeding status of each woman was correctly recorded and performed a review of a subsample of patient charts. Data analyses were done using SPSS 15.0 (SPSS inc, Chicago, Illinois) and the R© "cmprsk" package (23, 24) .
Outcomes and definitions
Patients who did not return to care for more than 180 days after their last visit were considered LTFU (25) . For the comparison with the historical cohort of Option A pregnant women we used a prospective LTFU definition (26) . Patients who missed their first follow-up visit after ART start and did not return to care for more than 180 days were considered to have 'no-follow up after ART initiation' (NFU). Patients were followed from initiation of ART to the date of the outcome of interest 
Statistical analyses
Baseline characteristics were compared between the different patient groups. Categorical variables were expressed as absolute frequencies and percentages. Continuous variables were expressed as means and standard deviation (SD) or medians and interquartile ranges (IQR). One sample Kolmogorov-Smirnov tests were performed to assess if variables were distributed normally. Normally distributed numeric parameters were compared between groups using the t test or ANOVA. Mann-
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were considered statistically significant.
RESULTS
Baseline characteristics
625 women of childbearing age started ART in Ancuabe district between July 2013 and June 2014. Of these, 308 initiated ART under Option B+ (243 "B+ pregnant", 65 "B+ lactating") and 317 for their own health. Baseline characteristics were similar between B+ pregnant and B+ lactating women, except for time between HIV diagnosis and ART start, which was longer in lactating women (18 vs. 8 days) (Table 1) . B+ pregnant were younger (p<0.001), had higher baseline CD4cell counts (p<0.001) and were less likely to be inWHO stage III or IV (p<0.001) than women in the "own health" group.
Time between HIV diagnosis and ART start was longest in the "own health" group (44 days). CD4 availability was higher in the "own health" group (82.0%), than in the "B+ pregnant" (39.1%) and the "B+ lactating" (56.9%) groups (Table 1) .
Retention in the different study groups
Over 333 women-years of follow-up, 3.7% of women died and 48.5% were LTFU. Among the latter, 25.6% were lost after the first visit (NFU). Median follow-up was 47 (interquartile range [ (IQR]: 1-245) days in "B+ pregnant", 185 (1-399) in "B+ lactating" and 239 (59-399) days in the "own health"
group. Overall 1-year retention was 61.9% in women treated for their own health, 40.4% in the B+ lactating group and 41.8% in the "B+ pregnant" group ( Figure 1 ). Death occurred in 6.3% of women in the "own health" group, 2.7% in the "B+ lactating" group and 1.2% in the "B+ pregnant" group (p<0. 001). B+ pregnant and lactating women were more likely to be LTFU in the first year (57% vs. 
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p<0. 001) than women starting ART for their own health. Figure 2 shows the cumulative incidence of death and LTFU in the three study groups.
In adjusted analyses, the risk of LTFU was higher in B+ pregnant women (asHR: 2.77; 95% CI: 
Comparison of outcomes with historical Option A cohort
Seventy-four pregnant women started ART under Option A between January 2011 and June 2013.
Pregnant women under Option A were less likely to have started ART at a peripheral type 2 HC (p<0.001) or to have an available CD4 cell count (p<0.001) but were more likely to have WHO stage III/IV (p<0.001) than "B+ pregnant" women (Table 1) . B+ pregnant women had higher baseline CD4 cell counts (p<0.001) and a shorter time from HIV diagnosis to ART initiation (8 vs. 51 days; p<0.001).
In adjusted analyses, B+ pregnant women were more likely to be LTFU (asHR: 1.91; 95% CI:1.40-2.60; p<0.001) and to have NFU (aOR: 3.33; 95% CI 1.50-7.40; p=0.003) than pregnant women on ART under Option A (Table 3) . A sensitivity analysis using the 90-day LTFU definition yielded similar results (Suppl. 
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DISCUSSION
In rural Mozambique, pregnant women who started ART under option B+ were three times as likely to be LTFU as women treated for their own health. A large proportion of those losses occurred early:
close to half of them did not return to the clinic after the day of ART initiation. Compared to outcomes from a historical cohort of option A pregnant women on ART, the risk of NFU was more than triple in B+ pregnant women.
Less than half of the B+ women were retained in care during the first year after ART start. These estimates remained similar when using a more stringent definition of LTFU (90 days). High LTFU rates have been described in pregnant women under option A and B , therefore suggesting that some of the factors underlying this poor retention may be a general problem of PMTCT and not specific to Option B+. However, the higher LTFU rate found in pregnant women starting ART under Option B+ compared to those starting under Option A may suggest that there could be factors specific to this new strategy, such as the lack of sufficiently trained staff or the short time between HIV diagnosis and ART start (32% of B+ PLW were started on ART the day they were diagnosed). Improvement of the District HIV program (ART regimens, CD4 availability) with time should have in any case benefited retention of Option B+ women. We would like to point out that most LTFU were very early losses (NFU), possibly related to the short time between diagnosis and ART start, and possibly indicating that many of those women never even got ART started.
We found higher overall LTFU rates than other studies (14, 15) but similar to previous reports from this rural setting and from other regions in Mozambique, where a high and increasing attrition rate during the ART expansion process in the country has been reported (32) . Undocumented transfers (33) or deaths could also partly explain this very high LTFU rate. Health system factors such as high direct and indirect costs of receiving care and insufficient expansion in the number of health staff could also have played a major role (34) . Although capacity-building and task shifting was implemented through various trainings, midwives still had very little experience in ART initiation and supervision was scarce.
Stigma and absence of community support may also have negatively contributed to retention (35) . In Mozambique, a strategy of community ART distribution through self-forming groups of patients was shown to be quite successful (36) (37) (38) , but pregnant women are excluded from these groups as they need close clinical follow-up. Despite the common counselling policy for all groups, more experienced counsellors and longer time available for counselling in the Chronic Diseases Units/HIV clinics may have contributed to the lower attrition rate of women seeking HIV care for their own health and Option A pregnant women. Active tracing was designed following national recommendations but was inconsistently done due to lack of transport and staff. No specific tracing
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strategy was designed for B+ women. Our results suggest that an improved and focused tracing strategy may be needed for Option B+ women.
We found better retention of B+ lactating women compared to B+ pregnant women. Other studies have also reported a higher attrition rate in pregnant women (15) . Women who start while lactating are probably a selection of those who are more motivated for ART so are more likely to be retained, as opposed to those who start during pregnancy who would be more likely to just take treatment until the baby is born.
Our study is among the first ones to compare retention of pregnant women starting ART before The high rate of LTFU described in our study could have severe consequences in terms of vertical transmission of HIV. Community-driven approaches or family-focused approaches could improve retention of pregnant women (41, 42) . Community ART dispensing programs have shown to improve
retention of HIV-infected patients in many Sub-Saharan African countries (43) but adapted solutions for PLW should be sought. Health system strengthening and ensuring that sufficient workforce is availableare key for this PMTCT strategy in such settings. Although the one-stop strategy has unquestionable advantages for PLW, shortage of sufficient skilled health staff may hamper its success and lead to worse retention rates when compared to those in ART clinics (44) . Future research should evaluate bottlenecks in the HIV care cascade and factors affecting retention to help design strategies to address high attrition in these women.
CONCLUSIONS
Our study shows very high proportions of early losses to follow-up in patients initiating ART under the option B+ strategy in rural Mozambique. These results underline some of the challenges related to the implementation of this strategy in settings with weak health care systems, insufficient ART counseling and retention measures. Our findings support the need for innovative strategies to improve retention as well as new service delivery models to address the barriers to successful HIV care for PLW.
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